NLS Economic Analysis

Strong demand for Finnish health technology products led to record exports totaling EUR 1.8 billion in 2014, an increase of 8.3 percent. Imports rose at a slower rate, but still posted another record trade surplus of EUR 829 million, up 10.7 percent.  Health technology is the largest high-tech export segment in Finnish industry, representing 47 […]

Mergers and acquisitions (M&A) activity lagged in the European biopharmaceutical market in 2014, analysts said. Healthcare investor HBM Partners presented the figures in its annual biotech M&A report. The $500 million European, VC-backed biotechs generated in upfront fees represents a 50 percent drop on 2013 and a 27 percent decrease compared with the mean of the […]

Pharmaceutical companies will suffer an estimated $65 billion drop in sales by 2019 due to the patent expirations of several leading drugs, and AstraZeneca will be one of the hardest hit, according to research and consulting firm GlobalData.  Besides AstraZeneca, the company’s report states that the drug makers hit hardest will include Otsuka and Eli […]

Health technology is now the largest and most significant high-tech segment in Finnish industry, representing 47 percent of Finland’s total high-tech product exports, according to FiHTA Healthtech Finland, an organization representing companies in the sector. The value of Finnish health technology product exports reached a new record of EUR 1.66 billion in 2013. Exports in the […]

Swedish Medtech Company Aerocrine was formed in 1997, based on research conducted at the Karolinska Institute investigating nitric oxide (NO) as an indicator for inflammatory processes, such as asthma. Aerocrine has developed devices to measure nitric oxide in exhaled air and these are used to both diagnose and follow the treatment of asthma. Aerocrine does […]

Karolinska Development has some interesting companies in its portfolio but has yet to show that it is capable of out-licensing projects to major pharmaceutical companies.